Kerala Ayurveda Ltd

Kerala Ayurveda Ltd (KERALAYUR) is a micro-cap Healthcare company valued at ₹190 crore operating in Pharmaceuticals on the NSE and BSE.

Recent price move

Kerala Ayurveda Ltd last traded at ₹144.85, modestly down 0.96% on the day.

Recent developments

On 2026-06-30, the company reported a net loss of ₹16 crore for the fiscal year ending March 2026, marking a widening loss compared to the previous year. Promoter shares pledged reached 20.35% of promoter holding as of June 2026, indicating potential liquidity concerns.

Financial performance

The company's revenue grew 9.0% annually, reaching ₹131 crore, but net profit turned into a loss of ₹16 crore, widening from a loss of ₹15 crore the previous year. In the latest quarter, revenue rose 16.0% year-on-year to ₹33 crore, but net profit swung from a profit of ₹2 crore to a loss of ₹8 crore.

Valuation multiples

A price-to-earnings ratio is not meaningful here because the company is loss-making; the stock trades at 20.10 times book value.

Things to watch

The company reported a net loss of ₹16 crore in the latest fiscal year, with a net profit margin of -12.4%, down 0.2 percentage points from the prior year. The debt to equity ratio stands at 7.77, indicating a highly leveraged position. The stock is 63.9% below its 52-week high, reflecting a significant decline in value.

Where it stands

Kerala Ayurveda Ltd ended its latest fiscal year with a net loss of ₹16 crore, while revenue grew 9.0% annually. The latest quarter saw revenue rise 16.0% year-on-year, but net profit turned to a loss of ₹8 crore. The stock is 63.9% below its 52-week high, and the company's debt to equity ratio remains at 7.77.

Summarised by DocStoX's model on 2026-10-18 from company filings, exchange data and news. This is a factual summary, not a rating or a recommendation. Informational only, not investment advice. Consult a SEBI-registered adviser before investing.